Pathophysiology and triggers of acute myocardial infarction: clinical implications.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 1350489)

Published in Clin Investig on January 01, 1992

Authors

S N Willich1, A H Jimenez, G H Tofler, R A DeSilva, J E Muller

Author Affiliations

1: Institute for Prevention of Cardiovascular Disease, Deaconess Hospital, Harvard Medical School, Boston.

Articles by these authors

Increased particulate air pollution and the triggering of myocardial infarction. Circulation (2001) 6.94

Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med (1993) 6.72

Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr (2001) 5.67

Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09

Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation (1995) 5.06

Circadian variation and triggers of onset of acute cardiovascular disease. Circulation (1989) 4.48

Circadian variation in the frequency of sudden cardiac death. Circulation (1987) 3.98

Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators. JAMA (1996) 3.94

Morning increase in onset of ischemic stroke. Stroke (1989) 3.52

Triggering myocardial infarction by marijuana. Circulation (2001) 3.36

Triggering of myocardial infarction by cocaine. Circulation (1999) 3.06

Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med (1987) 2.83

Cholecystokinin and its COOH-terminal octapeptide in the pig brain. Proc Natl Acad Sci U S A (1977) 2.62

Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation (2001) 2.54

Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol (2001) 2.50

Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol (1987) 2.27

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Ann Intern Med (1980) 2.19

Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol (1983) 2.18

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. Ann Intern Med (1980) 2.08

Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials. Lancet (1981) 2.01

Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol (1987) 2.01

Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. N Engl J Med (1986) 1.96

Leisure-time physical activity, television watching, and plasma biomarkers of obesity and cardiovascular disease risk. Am J Epidemiol (2000) 1.89

Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol (1994) 1.84

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA (2000) 1.83

The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol (1989) 1.80

Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation (2000) 1.70

Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. Am Heart J (1988) 1.69

Analysis of possible triggers of acute myocardial infarction (the MILIS study). Am J Cardiol (1990) 1.68

Hemostatic state and atrial fibrillation (the Framingham Offspring Study). Am J Cardiol (2001) 1.63

Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS). Am J Cardiol (1993) 1.63

Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J (1989) 1.62

Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol (1997) 1.61

Prior alcohol consumption and mortality following acute myocardial infarction. JAMA (2001) 1.61

Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury. Circulation (1975) 1.60

A simplified method to predict occurrence of complete heart block during acute myocardial infarction. Am J Cardiol (1986) 1.50

Immunohistochemical localization in rabbit brain of a peptide resembling the COOH-terminal octapeptide of cholecystokinin. Proc Natl Acad Sci U S A (1977) 1.46

Sudden cardiac death. Support for a role of triggering in causation. Circulation (1993) 1.45

The Soviet health system--aspects of relevance for medicine in the United States. N Engl J Med (1972) 1.43

Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion. Circulation (1976) 1.42

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation (1984) 1.41

Nifedipine therapy for Prinzmetal's angina. Circulation (1978) 1.41

Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population. Circulation (1997) 1.40

Pericarditis in acute myocardial infarction: characterization and clinical significance. Am Heart J (1989) 1.40

Educational attainment, anger, and the risk of triggering myocardial infarction onset. The Determinants of Myocardial Infarction Onset Study Investigators. Arch Intern Med (1997) 1.39

Use of auscultation to follow patients with mitral systolic clicks and murmurs. Am J Cardiol (1990) 1.39

Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. N Engl J Med (1977) 1.38

Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care (2001) 1.37

Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation (2000) 1.36

Implications for acute intervention related to time of hospital arrival in acute myocardial infarction. Am J Cardiol (1986) 1.33

Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol (1999) 1.33

Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation (1990) 1.32

Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol (1984) 1.29

Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol (1992) 1.21

Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. Am J Cardiol (2000) 1.20

Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation (1984) 1.18

Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation (2001) 1.18

Precordial electrocardiographic mapping. A technique to assess the efficacy of interventions designed to limit infarct size. Circulation (1978) 1.16

Morning peak in ventricular tachyarrhythmias detected by time of implantable cardioverter/defibrillator therapy. The CPI Investigators. Circulation (1995) 1.16

Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk. J Dent Res (2006) 1.14

Cardioversion and defibrillation. Am Heart J (1980) 1.13

Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. J Am Coll Cardiol (1992) 1.12

Sleep, dreams, and sudden death: the case for sleep as an autonomic stress test for the heart. Cardiovasc Res (1996) 1.11

Psychophysiologic factors in sudden cardiac death. Am J Psychiatry (1980) 1.09

Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab (2001) 1.08

A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. J Am Coll Cardiol (1999) 1.07

Roles of psychologic stress and autonomic nervous system changes in provocation of ventricular premature complexes. Am J Cardiol (1978) 1.06

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation (1995) 1.05

Increased risk of congestive heart failure among infarctions with nighttime onset. Am Heart J (2000) 1.02

Time of onset of symptoms of acute myocardial infarction. Am J Cardiol (1990) 1.02

Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB). Am J Cardiol (1997) 1.02

Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol (1988) 1.01

Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation (2001) 1.01

Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation (1995) 1.01

Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men. Am J Cardiol (1992) 1.01

Evaluation of sex-related differences in survival after hospitalization for acute myocardial infarction. Am J Cardiol (2001) 0.99

The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol (1989) 0.98

Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease. Circulation (1981) 0.97

Nonuniform nighttime distribution of acute cardiac events: a possible effect of sleep states. Circulation (1997) 0.97

Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study). Am J Cardiol (1989) 0.96

High-risk subgroups of patients with non-Q wave myocardial infarction based on direction and severity of ST segment deviation. Am Heart J (1987) 0.95

Health-manpower needs. N Engl J Med (1978) 0.95

Efforts to limit the size of myocardial infarcts. Ann Intern Med (1981) 0.95

Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation (1988) 0.94